proposed a reason for the failure of adoptive cellular immunotherapy in malignant glioma: immunosuppressive factors such as transforming growth factor-β (TGF-β) released from glioma cells inhibit T-cell proliferation and thus suppress immune responses. The gene discussed is TGFB1; the disease is malignant glioma.